Loading...
These two reports provide new information about the pharmacokinetics and pharmacodynamics of the relatively new antidepressant venlafaxine.
In the first study, researchers compared the bioavailability of two oral regimens of venlafaxine -- two daily doses of 75 mg each versus three daily doses of 50 mg each. Eighteen healthy volunteers were randomized to receive one of the regimens for 8 days and were then crossed-over to the other regimen for days 9 through 12. The daily dose was titrated up to 150 mg per day and held constant on days 5 through 12. Plasma concentrations of venlafaxine and its pharmacologically active metabolite O-desmethylvenlafaxine did not differ significantly between the two regimens for peak concentration area under the…